RxDoctor Payments Data

Lana Lyle

Family · Starkville, MSNPI 1568896165

Payments from drug & device makers

$1,845in general payments, 2019–2025

Across 60 payments — averaging $30.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$736
  • Amgen$264
  • Teva Pharmaceuticals USA, Inc.$205
  • AbbVie$183
  • Novo Nordisk$125
  • Si-bone, Inc.$100
  • plus $231 from 5 others

What the payments were for

  • Food & beverage$1,83199%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,845 in reported general payments places this provider in the 75th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$55,392
Medicare patients
253
Services billed
934

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nucynta ErTapentadol Hcl29$56,574
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,669$32,175
Buprenorphine85$26,330
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen623$16,815
LinzessLinaclotide27$16,615
Xtampza ErOxycodone Myristate14$11,116
MovantikNaloxegol Oxalate21$7,778
Fentanyl66$6,984
Gabapentin515$5,467
Oxycodone Hcl217$4,603
Acetaminophen-CodeineAcetaminophen With Codeine188$4,197
Pregabalin296$3,977
Tizanidine Hcl256$2,297
Tramadol Hcl293$1,934
Cyclobenzaprine Hcl239$1,839

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$183$16,61527 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,007 family providers in Mississippi.

Other family in Starkville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →